drugset / Trial / NCT04689425
Umbilical Cord Blood Mononuclear Cell Gel in the Treatment of Refractory Diabetic Foot Ulcer
RandomizedParallel-groupTriple-blindTreatment
Summary
Umbilical cord blood mononuclear cells (MNC) may improve the wound repair ability. This study aims to investigate the role of MNC in refractory diabetic foot ulcer by comparing the combination of PRP and MNC with PRP alone.
Timeline
- Start
- 2021-03-30
- Primary completion
- 2023-12-31
- Completion
- 2024-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Umbilical cord blood mononuclear cells | Cell therapy | — | Topical |
| Background | Platelet Rich Plasma | Other / unclassified | — | Topical |